Back to search
FDAFDA · Food and drugs·Recall number D-0857-2017

Children's Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30-count bottle, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol - 389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 47335-343-83.

Published May 31, 2017 · Recall initiated: April 18, 2017

Summary

FDA records drug Class III recall D-0857-2017, published May 31, 2017 and initiated April 18, 2017. Recalling firm: Sun Pharmaceutical Industries, Inc.; Status: Terminated; Reported quantity: 13,200 bottles; Lot: Lot #: JKR5135A, Exp 11/17. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sun Pharmaceutical Industries, Inc.
Distributor
Nationwide in the USA and Puerto Rico
Lot
Lot #: JKR5135A, Exp 11/17
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Children's Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30-count bottle, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol - 389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 47335-343-83. recalled?

Yes. FDA published recall D-0857-2017 on May 31, 2017. Reported hazard: Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.

What should I do if I have this product?

Voluntary: Firm initiated · Letter